The 4.5-Hour Time Window for Intravenous Thrombolysis With Intravenous Tissue-Type Plasminogen Activator Is Not Firmly Established

被引：8
|
作者：
Wechsler, Lawrence R. [1 ]
机构：
[1] Univ Pittsburgh, Sch Med, Dept Neurol, Pittsburgh, PA 15213 USA
来源：
STROKE | 2014年 / 45卷 / 03期
关键词：
tissue plasminogen activator; stroke; ACUTE ISCHEMIC-STROKE; RANDOMIZED CONTROLLED-TRIAL; ALTEPLASE;
D O I：
10.1161/STROKEAHA.113.002701
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：914 / 915
页数：2
相关论文
共 50 条
  • [1] 4.5-Hour Time Window for Intravenous Thrombolysis With Recombinant Tissue-Type Plasminogen Activator Is Established Firmly
    Schellinger, Peter D.
    Koehrmann, Martin
    STROKE, 2014, 45 (03) : 912 - 913
  • [2] Safety and Efficacy of Intravenous Recombinant Tissue Plasminogen Activator Administered in the 3-to 4.5-hour Window in Korea
    Park, Tai Hwan
    Lee, Ji Sung
    Park, Sang-Soon
    Ko, Youngchai
    Lee, Soo Joo
    Lee, Kyung Bok
    Lee, Jun
    Kang, Kyusik
    Park, Jong-Moo
    Choi, Jay Chol
    Kim, Dong-Eog
    Cho, Yong-Jin
    Kim, Joon-Tae
    Kim, Dae-Hyun
    Cha, Jae-Kwan
    Han, Moon-Ku
    Lee, Juneyoung
    Oh, Mi Sun
    Yu, Kyung-Ho
    Lee, Byung-Chul
    Bae, Hee-Joon
    Hong, Keun-Sik
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2014, 23 (07): : 1805 - 1812
  • [3] Cost-Effectiveness of Tissue-Type Plasminogen Activator in the 3-to 4.5-Hour Time Window for Acute Ischemic Stroke
    Tung, Christie E.
    Win, Sandra S.
    Lansberg, Maarten G.
    STROKE, 2011, 42 (08) : 2257 - 2262
  • [4] Number Needed to Treat to Benefit and to Harm for Intravenous Tissue Plasminogen Activator Therapy in the 3-to 4.5-Hour Window
    Saver, Jeffrey L.
    Gornbein, Jeffrey
    Grotta, James
    Liebeskind, David
    Lutsep, Helmi
    Schwamm, Lee
    Scott, Phillip
    Starkman, Sidney
    STROKE, 2009, 40 (07) : 2433 - 2437
  • [5] Intravenous thrombolysis for acute ischemic stroke in the 3-to 4.5-hour window - the Malabar experience
    Salam, Kizhakkaniyakath Abdu
    Ummer, Karadan
    Kumar, Vayyattu Govindankutty Pradeep
    Noone, Mohan Leslie
    INTERNATIONAL JOURNAL OF STROKE, 2014, 9 (04) : 426 - 428
  • [6] Outcomes of Intravenous Tissue Plasminogen Activator in the 3 to 4.5-hour Window for Acute Ischemic Stroke Patients with Prior Ischemic History and Diabetes Mellitus
    Hong, Keun-Sik
    Cho, Yong-Jin
    Park, Hong-Kyun
    Bae, Hee-Joon
    Kim, Beom Joon
    Park, Jong-Moo
    Kang, Kyusik
    Lee, Soo Joo
    Kim, Jae Guk
    Cha, Jae-Kwan
    Kim, Dae-Hyun
    Park, Tai Hwan
    Park, Sang-Soon
    Lee, Kyung Bok
    Lee, Jun
    Kim, Joon-Tae
    Park, Man-Seok
    Choi, Kang-Ho
    Cho, Ki-Hyun
    Lee, Byung-Chul
    Yu, Kyung-Ho
    Oh, Mi Sun
    Kim, Dong-Eog
    Ryu, Wi-Sun
    Choi, Jay Chol
    Kwon, Jee-Hyun
    Kim, Wook-Jo
    Shin, Dong-Ick
    Sohn, Sung Il
    Hong, Jeong-Ho
    Lee, Ji Sung
    Lee, Juneyoung
    CEREBROVASCULAR DISEASES, 2019, 48 : 64 - 65
  • [7] Community implementation of intravenous thrombolysis for acute ischemic stroke in the 3-to 4.5-hour window
    Montano, Arturo
    Staff, Ilene
    McCullough, Louise D.
    Fortunato, Gil
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2013, 31 (12): : 1707 - 1709
  • [8] Early intravenous thrombolysis with recombinant tissue-type plasminogen activator in vertebrobasilar ischemic stroke
    Grond, M
    Rudolf, J
    Schmülling, S
    Stenzel, C
    Neveling, M
    Heiss, WD
    ARCHIVES OF NEUROLOGY, 1998, 55 (04) : 466 - 469
  • [9] Intravenous recombinant tissue-type plasminogen activator thrombolysis in treatment of central retinal artery occlusion
    Kattah, JC
    Wang, DZ
    Reddy, C
    ARCHIVES OF OPHTHALMOLOGY, 2002, 120 (09) : 1234 - 1236
  • [10] Successful Emergency Carotid Endarterectomy after Thrombolysis with Intravenous Recombinant Tissue-Type Plasminogen Activator
    Yamamoto, Yoko
    Okazaki, Toshiyuki
    Yoda, Keishi
    Tada, Yoshiteru
    Nagahiro, Shinji
    JOURNAL OF MEDICAL INVESTIGATION, 2016, 63 (3-4): : 300 - 304
12345